These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors. Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML Virus Res; 2020 Nov; 289():198154. PubMed ID: 32918944 [TBL] [Abstract][Full Text] [Related]
9. Potential use of the S-protein-Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019. Feng L; Fu S; Zhang P; Zhang Y; Zhao Y; Yao Y; Luo L; Ping P Front Public Health; 2022; 10():1050034. PubMed ID: 36518573 [TBL] [Abstract][Full Text] [Related]
10. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase. Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676 [TBL] [Abstract][Full Text] [Related]
12. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. Li K; Meyerholz DK; Bartlett JA; McCray PB mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553 [TBL] [Abstract][Full Text] [Related]
13. Spatial Distribution of SARS-CoV-2 Receptors and Proteases in Testicular Cells. Ribeiro MR; Calado AM; Alves Â; Pereira R; Sousa M; Sá R J Histochem Cytochem; 2023 Apr; 71(4):169-197. PubMed ID: 37026452 [TBL] [Abstract][Full Text] [Related]
14. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141 [TBL] [Abstract][Full Text] [Related]
15. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections. Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922 [TBL] [Abstract][Full Text] [Related]
16. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes. Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095 [TBL] [Abstract][Full Text] [Related]
17. In Silico Analysis Reveals the Inhibitory Potential of Madecassic Acid against Entry Factors of SARS-CoV-2. Ganguly A; Mandi M; Dutta A; Rajak P ACS Appl Bio Mater; 2023 Feb; 6(2):652-662. PubMed ID: 36608326 [TBL] [Abstract][Full Text] [Related]
18. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566 [TBL] [Abstract][Full Text] [Related]
20. The Utility of Native MS for Understanding the Mechanism of Action of Repurposed Therapeutics in COVID-19: Heparin as a Disruptor of the SARS-CoV-2 Interaction with Its Host Cell Receptor. Yang Y; Du Y; Kaltashov IA Anal Chem; 2020 Aug; 92(16):10930-10934. PubMed ID: 32678978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]